TREM2 and neoplasm: Thus, we propose that TREM-1 may serve as a biomarker for tumor progression and a useful target for reprogramming the immunosuppressive tumor microenvironment of the host and that TREM2 might play an important role in balancing the inflammatory signals within the tumor.